Generic Pharmaceutical Company

NJ 2024 Independent Pharmacies

DOJ False Claims Act Anti Kickback

Penalty

$450 million

Outcome

Generic Pharmaceutical Company Pays $25 Million to Resolve False Claims Act Liability for Price-Fixing of Generic Drugs

Details

Generic Pharmaceutical Company — DOJ Enforcement (2024)

DOJ took enforcement action against Generic Pharmaceutical Company in NJ in 2024 involving false claims act, anti kickback violations in the Independent Pharmacies sector.

Penalty: $450 million

Violation types: False Claims Act, Anti Kickback
Entity type: Pharmacy
Penalty type: Criminal
Location: NJ

Source: DOJ Press Release — Generic Pharmaceutical Company Pays $25 Million to Resolve False Claims Act Liability for Price-Fixing of Generic Drugs

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.

Source: DOJ Press Release — Generic Pharmaceutical Company Pays $25 Million to Resolve False Claims Act Liability for Price-Fixing of Generic Drugs

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works